Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo
Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
10/2012
10/31/2012CN101927008B Diagnostic and therapeutic gastric cancer vascular specific binding peptide GEBP11 isotope probe
10/30/2012US8299030 Peptide-based compounds
10/30/2012US8298582 Polysaccharide-based impregnated solid material with improved stability, processes for the preparation thereof and impregnating solutions used
10/30/2012CA2447025C Systems, methods and devices for in vivo monitoring of a localized response via a radiolabeled analyte in a subject
10/30/2012CA2411374C Dual specificity antibodies and methods of making and using
10/30/2012CA2215161C Proteinase k resistant surface protein of neisseria meningitidis
10/26/2012WO2012145125A1 Targeted radionuclides
10/26/2012WO2012144716A1 Nanoparticle-based vaccine delivery system having double functions of imaging and delivery
10/26/2012WO2012143713A2 Cancer therapy
10/26/2012WO2012142687A1 Antitumour testosterone-(radioactive iodine) compound
10/26/2012WO2012142659A1 Site-selective modification of proteins
10/26/2012WO2012110835A3 Prussian blue based nanoparticle as multimodal imaging contrast material
10/25/2012US20120269773 Recombinant adenoviruses encoding the specific iodine transporter (nis)
10/25/2012US20120269727 Imaging agents with improved pharmacokinetic profiles
10/25/2012US20120269726 Heterodimers of Glutamic Acid
10/25/2012US20120269725 Targeted radiolabeled compounds and their use for the treatment and diagnosis of cancer
10/25/2012US20120269724 Compositions and methods for imaging tissues, organs and tumors
10/25/2012US20120269723 Complex of bi-specific antibody and digoxigenin conjugated to a therapeutic or diagnostic agent
10/25/2012US20120269722 Chemoembolisation
10/25/2012US20120269721 Targeted nanoclusters and methods of their use
10/25/2012US20120269720 Detection of hepatic insulin resistance
10/24/2012EP2514442A2 Imaging diagnostics by combining contrast agents
10/24/2012EP2513121A1 Prostate specific membrane antigen inhibitors
10/24/2012EP2512525A1 Aryloxyanilide imaging agents
10/24/2012EP2512523A1 Labelled integrin binders
10/24/2012CN102753561A Method for producing 18F-labeled compound and high molecular compound to be used in the method
10/24/2012CN102747039A Tumor-associated antigen, monoclonal antibody and purpose thereof
10/24/2012CN102746315A Preparation method and use of 10-<11>C-methoxycamptothecin
10/24/2012CN102743770A Targeting molecular imaging probe and living molecular imaging method
10/24/2012CN102120039B Use of carbon-11 marked N-methyldopamine hydrochloride in preparation of positron medicinal imaging agent
10/24/2012CN101850128B 188Re-labelled folic acid coupled cis-platinum magnetic albumin compound nano-particle as well as preparation method and application thereof
10/23/2012US8293702 Phenolic binding peptides
10/23/2012US8293209 System for delivering therapeutic agents into living cells and cells nuclei
10/23/2012US8293207 Radiometal-labeled amino acid analogs, imaging and therapeutic agents incorporating the same, and methods using the same
10/23/2012CA2454275C Conformationally constrained parathyroid hormone (pth) analogs
10/23/2012CA2373475C Novel cyanine and indocyanine dye bioconjugates for biomedical applications
10/23/2012CA2284829C Immunotherapy of b-cell malignancies using anti-cd22 antibodies
10/23/2012CA2219119C Nucleic acid ligand complexes
10/18/2012WO2012072736A3 Radioconjugation method
10/18/2012WO2011115812A8 Affinity peptides toward bmp-2
10/18/2012US20120263790 Methods of diagnosing and treating small intestinal bacterial overgrowth (sibo) and sibo-related conditions
10/18/2012US20120263646 Imaging agents and their use for the diagnostic in vivo of neurodegenerative diseases, notably alzheimer's disease and derivative diseases
10/18/2012US20120263645 Radiolabeled compound directable in vivo to target tissue and use thereof
10/18/2012US20120263644 Treatment and diagnosis of inflammatory disorders and hiv
10/18/2012US20120263643 Brachytherapy seed
10/17/2012EP2510952A1 A radioactive surface source and a method for producing the same
10/17/2012EP2510951A1 Molecular probe for imaging of pancreatic islet, and use thereof
10/17/2012EP2509938A1 Fty720 halogenated derivatives
10/17/2012EP2509638A1 Iodine radiolabelling method
10/17/2012EP2509637A2 Purification method
10/17/2012CN102741264A Prostate specific membrane antigen inhibitors
10/17/2012CN102741169A Method and device for producing 99mtc
10/17/2012CN102731432A Fluorination process of anilide derivatives and benzothiazole fluorinate derivatives as in vivo imaging agents
10/17/2012CN102727913A Preparation method of iodine-labeled gelatin microspheres with high labeling rate
10/17/2012CN102727911A Diamino polyethylene glycol modified paramagnetic metal complex magnetic resonance imaging contrast agent
10/16/2012US8288349 Conjugated to antibody; thrombospondin receptor targeting
10/16/2012US8287850 Conjugates of hydroxyalkyl starch and a protein, prepared by reductive amination
10/16/2012US8287840 Method of treating malignant solid tumors using transcatheter arterial chemoembolization (TACE)
10/16/2012US8287839 Low toxicity boronated porphyrins for use in the treatment, visualization, and diagnosis of tumors via boron neutron capture therapy (BNCT), X-ray radiation therapy (XRT), and photodynamic therapy (PDT); brain, head and neck tumors; diagnosis
10/16/2012US8287819 Divided bottle; monitoring transfer between compartments; removal, disposable module
10/16/2012CA2614615C Melanocortin receptor ligands
10/16/2012CA2516028C Conjugates comprising a cancer targeting molecule linked to a liver-expressed chemokine
10/11/2012WO2012139069A2 Compositions and methods for treating diseases of protein aggregation involving ic3b deposition
10/11/2012WO2012138749A1 Methods for decreasing ocular toxicity of antibody drug conjugates
10/11/2012WO2012138251A1 Octapeptide, radiopharmaceutical agent based thereon and method for diagnosing tumors
10/11/2012WO2012135937A1 Protein kinase inhibitors
10/11/2012US20120259267 Chemically Amplified Response Strategies for Medical Sciences
10/11/2012US20120258102 Combination therapies for b-cell lymphomas comprising administration of anti-cd20 antibodies
10/11/2012US20120258101 Combination therapies for b-cell lymphomas comprising administration of anti-cd20 antibody
10/11/2012US20120258043 Linkable Lewis X Analogs
10/11/2012US20120258042 Combined use of tgf-b signaling inhibitor and antitumor agent
10/11/2012US20120258041 Compositions and methods for treating diseases of protein aggregation involving ic3b deposition
10/11/2012US20120258040 Compositions and methods of monoclonal and polyclonal antibodies specific for t cell subpopulations
10/11/2012US20120258039 Treatment of tumors using specific anti-l1 antibody
10/11/2012US20120258038 Uses of apoptotic cell-targeting peptides, label substances and liposomes containing a therapeutic agent for preventing, treating or therapeutically diagnosing apoptosis-related diseases
10/11/2012CA2832106A1 Compositions and methods for treating diseases of protein aggregation involving ic3b deposition
10/11/2012CA2831843A1 Protein kinase inhibitors
10/10/2012EP2508505A1 Method for high-speed fluoromethylation and process for preparation of pet tracer using same
10/10/2012EP2507254A1 Methods and compositions for improved f-18 labeling of proteins, peptides and other molecules
10/10/2012EP2506881A1 Combining radioimmunotherapy and antibody-drug conjugates for improved cancer therapy
10/10/2012EP2506876A2 J591 minibodies and cys-diabodies for targeting human prostate specific membrane antigen (psma) and methods for their use
10/10/2012CN102725003A Aldehydes for in vivo imaging of aldh in cancer stem cells
10/10/2012CN102725000A Novel class of monospecific and bispecific humanized antibodies that target the insulin-like growth factor type i receptor (IGF-1R)
10/10/2012CN101857561B Preparation method of N-ethyl-N2S2-memantine
10/10/2012CN101035567B Novel technetium and rhenium complexes, ligands used in their preparation and their use as radiopharmaceuticals
10/09/2012US8283321 Kallikrein-binding “Kunitz domain” proteins and analogues thereof
10/09/2012CA2660425C Composition apparatus and method for use in imaging
10/09/2012CA2476901C Anti-ccr5 antibody
10/09/2012CA2358517C Method and composition for angiogenesis inhibition
10/04/2012WO2012135675A2 Methods for increasing efficacy of folr1 cancer therapy
10/04/2012WO2012135360A1 Binding proteins specific for egfr expressed on tumor and uses thereof
10/04/2012WO2012131378A2 Pharmaceutical preparation
10/04/2012WO2012131037A1 Radiolabelled flumazenil derivatives
10/04/2012WO2012129673A1 INHIBITORS OF 17ß-HSD1, 17ß-HSD3 AND 17ß-HSD10
10/04/2012US20120251555 Antibodies against t cell immunoglobulin domain and mucin domain 1 (tim-1) antigen and uses thereof
10/04/2012US20120251535 Combination therapies for b-cell lymphomas comprising administration of anti-cd20 antibody
10/04/2012US20120251534 Combination therapies for b-cell lymphomas comprising administration of anti-cd20 antibody
10/04/2012US20120251532 Anti-alpha v beta 6 antibodies
10/04/2012US20120251449 Aldh: a compound for cancer stem cell imaging
10/04/2012US20120251448 Compounds for Use in the Detection of Neurodegenerative Diseases
1 ... 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 ... 243